HERCULES: a three-arm noninferiority trial of a anti-HER2 cancer vaccine
Published:
As part of UW Biostat course, we authored a mock protocol for an original clinical trial comparing a novel anti-HER2 cancer vaccine (HER-Vaxx) plus chemotherapy to trastuzumab plus chemotherapy versus chemotherapy alone for treatment of advanced/metastatic HER2-posite Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma. You can find the protocol here along with a short slide deck.